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CVD is associated with a cellular inflammatory/immune response. n-3 PUFA and moderate aerobic exercise independently alter cytokine
production and leucocyte function. There is limited evidence for the combined effect of these treatments on immune function, particularly in
patients with risk factors for CVD. We hypothesised that exercise would enhance the anti-inflammatory effects of n-3 PUFA. In a randomised,
placebo-controlled study, fifty volunteers were allocated double-blind to consume either sunflower oil (6 g/d, placebo) or DHA-rich fish oil
(6 g/d; about 2 g n-3 PUFA; 1·6 g DHA /d) for 12 weeks. Volunteers were further randomised to undertake regular exercise (walking 3 d/week
for 45min at 75% of maximum heart rate) or maintain their usual physical activity for 12 weeks. Immune functions were assessed in blood
taken initially and after 12 weeks. There was no effect on cytokine production by T cells and monocytes. Superoxide anion production from stimu-
lated blood neutrophils was decreased by fish oil (19·5 (SEM 8·5) %, P¼0·016) but not by exercise, and this change was negatively correlated with
the incorporation of DHA into erythrocytes (r–0·385, P¼0·047). Participation in regular exercise maintained neutrophil bactericidal activity,
which decreased in non-exercising subjects (2·9 (SEM 0·7) %, P¼0·013). Neutrophil chemotaxis and adherence were not significantly affected
by exercise, oil, or the combination of the two. Thus the combination of moderate exercise and fish-oil supplementation, which reduces
cardiovascular risk, may also help to counteract inflammation.
n-3 PUFA: Exercise: Neutrophils: T cells: Monocytes: Cytokines
Fish oils, which are rich in n-3 PUFA, particularly DHA
(22 : 6n-3) and EPA (20 : 5n-3), have been shown to suppress
a range of components of inflammatory/immune reaction1.
The anti-inflammatory nature of n-3 PUFA has generally
been attributed to the inhibitory effects of EPA on the
synthesis of eicosanoids from the n-6 PUFA, arachidonic
acid (AA). EPA prevents the mobilisation of AA from cell
membranes by phospholipase A2
2 and competitively inhibits
the oxygenation of AA by cyclo-oxygenase and 5-lipoxygen-
ase3. Eicosanoids synthesised from EPA have substantially
less inflammatory activity than those derived from AA4.
Furthermore, supplementation with dietary fish oil has been
reported to reduce the production of inflammatory cytokines
such as IL-1, IL-6, and TNF-a5–8, and to suppress the
expression of vascular cell adhesion molecule-19. n-3 PUFA
may exert their effects on immune cells by altering membrane
fluidity10, or cell signalling pathways1 and this may also
explain the ability of fish oil to alter the function of
leucocytes, particularly neutrophils10.
While neutrophils are important mediators of host defences,
they also contribute to tissue damage11 and have been
implicated as a cause of injury during myocardial ischemia-
reperfusion12. Previous studies have reported decreases in
neutrophil chemotaxis3,13, adhesion14,15, and superoxide
anion production with n-3 supplementation16–19, but other
reports have found no effect on any of these measures of
neutrophil function20–23. It is possible that this disparity is
due to differences in fish-oil dose and the relative concen-
trations of EPA and DHA. Most studies have evaluated the
effects of supplementation with EPA-rich oils rather than
DHA-rich oils24.
The anti-inflammatory effects of exercise have also been
investigated and several studies have shown a reduction in
inflammatory markers involved in the pathogenesis of athero-
sclerosis, including C-reactive protein, interferon g (IFNg),
TNF-a, IL-1 and IL-625–27. Furthermore, population studies
demonstrate an inverse relationship between physical activ-
ity and fitness, and markers of inflammation, particularly
C-reactive protein28–30. The effect of exercise on neutrophil
function is less clear31 and limited to the effects of an acute
exercise bout; however these reports are inconsistent and
likely to be confounded by factors such as training status,
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exercise intensity and population differences31,32. Fewer
studies have investigated the effect of regular exercise training
on neutrophil function, although there is some evidence to
suggest that it may reduce neutrophil respiratory burst activity.
In light of these findings, exercise may have important impli-
cations in the prevention of vascular and inflammatory
diseases.
Only two studies have investigated the combined effect of
regular exercise and n-3 PUFA supplementation on inflam-
mation or immune function. Using a rat model, Robinson &
Field33 observed an increase in splenic natural killer cell
cytotoxicity in sedentary but not exercise-trained animals
supplemented with n-3 PUFA. In trained runners, n-3 PUFA
supplementation failed to attenuate plasma levels of TNFa,
IL-6 and transforming growth factor-b compared to placebo,
following a strenuous exercise session34. Given the potential
for n-3 PUFA and exercise to independently influence leuco-
cyte function, we hypothesised that n-3 PUFA would enhance
the anti-inflammatory effects of regular moderate exercise.
Consequently, this 12-week intervention study evaluated the
independent and combined effects of supplementation with a
DHA-rich tuna fish oil and regular moderate exercise, on
neutrophil function in overweight adults exhibiting cardio-
vascular risk factors.
Materials and methods
This study focused on changes in immune response as part of
a larger trial investigating the effects of supplementation with
DHA-rich tuna fish oil and regular aerobic exercise on cardi-
ovascular and metabolic outcomes.
Subjects
Overweight and obese (BMI .25 kg/m2) adult (25–65 years
of age) subjects who exhibited at least one of the following
cardiovascular risk factors : mild hypertension (systolic
blood pressure 140–160mmHg or diastolic blood pressure
90–100mmHg), elevated plasma TAG .1·6mmol/l or elev-
ated total cholesterol .5·5mmol/l were recruited for a
12-week randomised, double-blind, parallel, placebo-con-
trolled 2 £ 2 factorial trial. Volunteers completed a diet and
lifestyle questionnaire to determine initial suitability for the
study. Exclusion criteria included smoking, lipid or blood
pressure-lowering medications, diagnosed CVD or kidney dis-
ease, diabetes, prior consumption of fish-oil supplements and/
or consuming two or more servings of oily fish per week, and
regular participation in more than one physical activity session
per week. To confirm eligibility, subjects attended a screening
appointment to assess height, weight, blood pressure, and fast-
ing TAG and total cholesterol concentrations in venous blood.
Subjects also completed a medical screening, which included
electrocardiogram monitoring (Nihon Kohden, Tokyo, Japan)
during a graded exercise test to confirm their suitability for
exercise training.
Fifty subjects, fourteen male and thirty-six female (age 50
(SEM 1) years), were enrolled in the study in two intakes,
one in winter and one in summer, thus countering any
potential seasonal variation in immune function. Ethics
approval was obtained from both the University of South
Australia and the University of Adelaide and written informed
consent was obtained from all subjects prior to their
participation.
Study design
Subjects were assigned to one of four intervention groups,
which were matched for sex, BMI and TAG. These groups
were then randomly allocated to consume six 1 g capsules of
either DHA-rich tuna fish oil (Hi-DHAw; Nu-Mega Ingredients
Pty Ltd, Brisbane, Australia), which provided 260mg DHA
and 60mg EPA in each 1 g capsule, or sunflower oil, daily
for 12 weeks. All capsules were identical in colour and
shape. Peppermint essence was added to each capsule to
ensure blinding to taste. Half of each of the fish oil and sun-
flower oil groups were further randomised to undertake
exercise (FOX, SOX) or maintain their usual physical activity
(FO, SO).
Subjects allocated to an exercise group (FOX and SOX)
were required to run or walk for 45 minutes, three times per
week at a heart rate corresponding to 75% of their age-pre-
dicted maximum (208–(0·7 £ age)35, i.e. a moderate exercise
intensity. Subjects were asked to maintain their usual physical
activity and diet with the exception of the exercise interven-
tion and supplementation. Fasting blood samples were col-
lected at Baseline (week 0), week 6 and week 12 of the
intervention period. Subjects completed a 3-d physical activity
diary (adapted from Bouchard36) and a weighed food record
(analysed using Foodworks Professional Edition, Xyris
Software, Version 3.02; Highgate Hill, Australia) on two
weekdays and one weekend day prior to attending their sched-
uled clinic visits at weeks 0, 6 and 12.
Erythrocyte fatty acids
Erythrocyte fatty acid composition was determined at weeks 0,
6 and 12. Erythrocytes were isolated, washed with isotonic
saline (0·9%), frozen, thawed then lysed in hypotonic 0·01M
Tris EDTA buffer, pH 7·4 and the membrane lipids were
extracted and transmethylated according to the method of
Lepage & Roy37. Fatty acid methyl esters were analysed
using a Shimadzu gas chromatograph 20A (Shimadzu Corpor-
ation, Kyoto, Japan) fitted with a flame ionisation detector and
a 50m BPX70 column (0·32mm internal diameter and
0·25mm film thickness; SGE Analytical Science, Ringwood,
Australia). Individual fatty acids were identified by compari-
son with known fatty acid methyl ester standards (Nuchek
Prep Inc., Elysian, USA) and expressed as a percentage of
total fatty acids.
Leucocyte preparation
Blood samples were collected in heparinised tubes at weeks 0
and 12, and separated into mononuclear leucocytes (MNL)
and neutrophils, .96% purity and .99% viable, by centrifu-
gation on Hypaque-Ficoll of density 1·4438. This was prepared
by mixing Ficoll 400 (Amersham Pharmacia, Uppsala,
Sweden) with sodium diatrozoate (Sigma Aldrich, St Louis,
USA) and Angiografin (Schering pty Ltd, Sydney, Australia).
Leucocyte functions were conducted under conditions accre-
dited by the National Association of Testing Authorities of
n-3 PUFA, exercise and neutrophil function 301
Australia (NATA). This ensures a limited degree of variability
between testing conducted at different times.
Neutrophil functions
Superoxide anion production was measured spectrophotome-
trically using the nitroblue tetrazolium reduction test39.
Briefly, 100ml neutrophils (5 £ 106/ml) in Hanks’ balanced
salt solution (HBSS) were treated with 250ml phorbol myris-
tate acetate (PMA) (0·4mg/ml), or diluent (250ml HBSS).
500ml nitroblue tetrazolium solution (Sigma Aldrich,
St Louis, USA) was added to each tube and allowed to incu-
bate for 20min at 37 8C. The tubes were then centrifuged
(600 g for 5min) and neutrophils resuspended in 200ml of
ethanol–PBS (1 : 1, v/v) to lyse cells. Following incubating
at room temperature for 30min, the 200ml suspensions were
transferred to wells in a microtitre tray. Absorbance was
measured at 570 nm using a Dynatech MR 7000 plate reader
(Dynatech Laboratories, Chantilly, USA).
Neutrophil chemotaxis was determined by measuring neu-
trophil migration under agarose using the chemotactic agent
f-met-leu-phe (Sigma), as previously described40. Bactericidal
activity was assessed by determining viability of bacteria at 0
and 60min, following incubation of neutrophils with comp-
lement treated Staphylococcus aureus (strain 6571; National
Collection of Type Cultures, Oxford, England), as described
previously41. Neutrophil adherence was measured by adher-
ence to plasma-coated plates, according to the method of
Powell42.
Cytokine production from stimulated mononuclear leucocytes
MNL were cultured in the presence or absence of the T lym-
phocyte mitogens, phytohaemagglutinin (2mg/ml; Murex
Diagnostics, Dartford, England) or Concanavalin A (40mg/
ml; Sigma)43 for 72 h at 378C in CO2–air (5%, v/v) and
high humidity. Cytokine production (lymphotoxin, IFNg and
IL-2) was measured in the culture supernatants by ELISA
using cytokine-specific monoclonal antibodies, as described
by Costabile43. Cytokine production by monocytes (TNFa,
IL-1b, IL-6) was examined by stimulating MNL with bacterial
lipopolysaccharide (1mg/ml) for 24 h as above44. Absorbance
at 450/750 nm was read using a Dynatech MR 7000 plate
reader (Dynatech Laboratories). The limit of detection for
all cytokines was approximately 0·02 ng/ml. The inter-assay
CV were ,8% for lymphotoxin, IL-1b, IL-2 and IL-6, and
,16% for IFNg and TNFa. The intra-assay CV were
,6% for all cytokine assays.
Statistical analysis
This study was a sub-study of a larger trial where sample size
was determined based on a metabolic-related primary outcome
measure. Data were analysed using Statistica for Windows
(Version 5·1, StatSoft Inc., Tulsa, USA). Differences at baseline
(week 0) were determined by one-way ANOVA. Treatment
effects and their interactions over time were assessed by 3-
factor ANOVA with repeated measures with oil treatment
(fish oil or sunflower oil) and exercise treatment (exercise or
non-exercise) being the between-group factors and time
(weeks 0 and 12) being the within-subject repeated measure-
ment. Where a significant difference was detected at baseline,
data were analysed by 3-factor ANCOVA (oil £ exercise £
time), which assessed changes in select parameters with the
baseline values included as a covariate. Where ANOVA
showed a significant main effect, differences between means
were identified post hoc using Tukey’s procedure. Pearson pro-
duct-moment correlation coefficients were used to describe the
relationship between two different variables. A probability
value of P,0·05 was considered statistically significant.
Values are expressed as means with their standard errors.
Results
Subjects and protocol compliance
Of the fifty subjects initially enrolled, five withdrew prior to
beginning or during the trial : three subjects had a change in
work or family circumstances, one did not consume the
required number of daily capsules, and another was lost to
follow up. Five subjects failed to comply with the exercise
requirements and were excluded. None of the subjects experi-
enced adverse effects of the treatment. Baseline (week 0)
characteristics for subjects who completed the 12-week inter-
vention (forty subjects) are listed according to treatment
group in Table 1. There were no differences between groups
Table 1. Baseline (week 0) characteristics of study participants
(Mean values with their standard errors)
Treatment group
FO (n 11) FOX (n 10) SO (n 11) SOX (n 8)
Mean SEM Mean SEM Mean SEM Mean SEM P *
Sex (male : female) 3 : 8 2 : 8 4 : 7 2 : 6 0·88
Age (years) 52 2 49 2 50 3 51 2 0·84
BMI (kg/m2) 35 2 34 2 35 1 34 1 0·99
Body fat (%) 45 1 46 2 45 2 45 3 0·95
Systolic blood pressure (mmHg) 128 5 132 5 128 3 133 3 0·75
Diastolic blood pressure (mmHg) 70 3 77 3 72 2 78 3 0·17
TC (mmol/l) 6·8 0·5 6·1 0·5 6·3 0·6 6·9 0·6 0·70
TAG (mmol/l) 1·6 0·3 1·5 0·2 1·5 0·2 1·8 0·3 0·79
FO, fish oil; FOX, fish oil and exercise; SO, sunflower oil; SOX, sunflower oil and exercise; TC, total cholesterol.
* There were no significant differences for any variable.
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at baseline. Analysis of physical activity and diet diaries
showed good compliance with the dietary and physical
activity requirements for the trial (data not shown). There
was no change in energy intake (assessed by weighed food
records) in any of the treatment groups and .85% of exercis-
ing subjects completed the required number of exercise train-
ing sessions.
Effects on erythrocyte fatty acid concentrations
Due to mishandling of blood samples, some data were lost to
analysis and consequently fatty acid profiles of erythrocyte
membranes were only obtained from 27 subjects at weeks 0,
6 and 12 (Table 2). However, the data show little variation
and therefore appear to be representative of the total sample.
There were no differences in EPA or DHA concentrations
between groups at week 0 (one-way ANOVA, P¼0·13 and
P¼0·57, respectively). However, DPA concentration was sig-
nificantly greater in the SOX v. FOX group at week 0
(Tukey’s test, P¼0·019). One-way ANOVA also detected a
significant difference between groups for total n-3 concen-
trations at week 0, and post hoc analysis indicated that the
total long chain n-3 PUFA concentration in SOX was signifi-
cantly greater than SO (P¼0·033).
The percentage of total long chain n-3 PUFA in erythro-
cytes rose progressively in the FO and FOX groups during
the 12-week supplementation period : from 10·2 to 13% in
the FO group and from 10 to 13·3% in the FOX group. This
increase was statistically significant (ANCOVA oil £ time
interaction for total long chain n-3 PUFA, P,0·002) and
entirely attributed to the change in DHA, which increased by
80% in FO and 85% in FOX (ANOVA oil £ time interaction
for DHA, P,0·001). Total long chain n-3 PUFA and DHA
content remained unchanged in the SO and SOX groups.
Post hoc analysis detected a marginal reduction in EPA for
all subjects during the intervention (main effect of time,
P,0·013).
Effects on neutrophil functions
There were no significant differences between groups for any
measure of neutrophil function at baseline (Table 3). ANOVA
did not detect any 3-factor interactions for any of these
measures. However, a significant 2-factor oil £ time inter-
action was detected for superoxide production (P¼0·016).
There was a significant decrease in superoxide production in
the combined fish oil group (219·5 (SEM 8·5)%, P¼0·041)
with no change in the combined sunflower oil group (10·7
(SEM 14)%, P¼0·82). Superoxide production was negatively
correlated with DHA concentration in erythrocyte membranes
(r 20·385, P¼0·047). A significant 2-factor exercise £ time
interaction was detected for bactericidal activity (P¼0·013).
Subjects who did not participate in the exercise programme
had a significant reduction in bactericidal activity by week
12 (Tukey’s test, P¼0·002), while the exercise group
remained unchanged (P¼0·99). For all subjects, there was a
main effect of time on adherence, which increased during
the intervention (Table 2, P,0·05).
Effect on T cell and monocyte function
Concanavalin A and phytohaemagglutanin were used to
examine any effects on the ability of T cells in the MNL
fraction to produce cytokines (lymphotoxin, IFN-g, IL-2)
Table 2. Erythrocyte fatty acid composition (% of total fatty acids) at week 0 and after 6 and 12 weeks of intervention with fish oil (FO) and exercise
(FOX) or sunflower oil (SO) and exercise (SOX)
(Mean values with their standard errors)
Treatment group
FOX FOX SO SOX
Mean SEM Mean SEM Mean SEM Mean SEM
EPA*† week 0 1·75 0·07 1·57 0·07 1·46 0·11 1·73 0·11
week 6 1·71 0·05 1·49 0·05 1·39 0·11 1·62 0·06
week 12 1·62 0·07 1·49 0·06 1·36 0·12 1·63 0·07
n 7 9 4 7
DPA† week 0 4·66 0·15 4·50a 0·11 4·49 0·11 5·30b 0·30
week 6 4·49 0·12 4·33 0·13 4·11 0·28 4·92 0·12
week 12 4·48 0·13 4·48 0·10 4·00 0·24 4·99 0·16
n 7 9 4 7
DHA*‡ week 0 3·83 0·19 3·97 0·34 3·40 0·15 3·53 0·32
week 6 6·12 0·16 6·30 0·29 3·53 0·33 4·19 0·22
week 12 6·89 0·17 7·35 0·33 3·62 0·14 4·20 0·17
n 7 9 4 7
Total n-3 PUFA*‡ week 0 10·24 0·25 10·04 0·27 9·34a 0·16 10·56b 0·20
week 6 12·32 0·22 12·13 0·32 9·02 0·52 10·73 0·35
week 12 13·00 0·22 13·33 0·33 8·98 0·38 10·82 0·34
n 7 9 4 7
DPA, docosapentaenoic acid.
Mean values within a row with different superscript letters are significantly different (1-factor ANOVA, P,0·05). No 3-factor interactions were detected.
* Significant main effect of time, P,0·05.
† Significant 2-factor oil £ exercise interaction, P,0·05.
‡ Significant 2-factor oil £ time interaction, P,0·05.
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and lipopolysaccharide to stimulate monocyte cytokines
(IL-1b, TNF and IL-6) in the MNL. The production of cyto-
kines from concanavalin A, phytohaemagglutanin and lipopo-
lysaccharide stimulated MNL did not differ between groups at
baseline, and remained unchanged following the 12-week
intervention, although ANOVA detected a significant main
effect of time for several of these cytokines (Table 4).
Discussion
The data presented demonstrate that there is no interactive
effect of regular aerobic exercise training and n-3 PUFA
supplementation on T cell and monocyte responses to phyto-
haemagglutanin/Concanavalin A and lipopolysaccharide
respectively, in an overweight population with risk factors
for CVD. The T cell responses were measured in terms of pro-
duction of the T helper 1 cytokines, lymphotoxin, IFN-g and
IL-2, while for monocytes, IL-1b, TNF and IL-6 production
was assessed. While the combined effects of these treatments
on inflammation and immunological parameters have not pre-
viously been investigated, others have shown that both n-3
PUFA and regular exercise independently reduce risk factors
for CVD and mortality45,46 and modulate inflammatory mar-
kers26,47, but these differences may be related to variations
in dose and type of n-3 PUFA used48.
In this study, subjects were supplemented with DHA-rich
fish oil, providing a total n-3 PUFA intake of about 2·0 g/d,
of which about 1·6 g/d was DHA. As expected, the concen-
tration of total long chain n-3 PUFA in erythrocyte mem-
branes increased progressively during the 12-week
intervention. This change was entirely attributable to a sub-
stantial increase in DHA, the incorporation of which into
erythrocyte membranes may have displaced EPA and could
account for the observed reduction in EPA during the inter-
vention. Additionally subjects may have reduced their con-
sumption of fish and EPA from other sources, although it
should be emphasised that baseline fish consumption was
less than two servings of oily fish per week, and subjects
taking fish- oil capsules were excluded. There is good evi-
dence that the incorporation of n-3 PUFA into erythrocytes
mimics the incorporation into other tissues49. Supplementation
resulted in a near doubling of DHA in erythrocyte membranes.
Comparable changes have been observed in platelets, mono-
nuclear cells50,51 and neutrophils52, although there is some
degree of variability in the time course for incorporation50.
Unlike DHA, EPA competes directly with AA as a substrate
for cyclo-oxygenase and 5-lipoxygenase53, which leads to the
production of less potent inflammatory eicosanoids than are
produced from AA. In comparison, DHA may exert anti-
inflammatory effects by (i) inhibiting gene expression of
enzymes involved in eicosanoid synthesis54;(ii) conversion
into highly anti-inflammatory compounds55; or (iii) inhibiting
expression of inflammatory mediators1,56. There is however
limited data directly comparing the immunomodulatory prop-
erties of DHA and EPA. Supplementation with DHA but not
EPA has been reported to suppress T lymphocyte activation52,
although neither EPA nor DHA affected neutrophil function,
cytokine production by MNL or adhesion molecule
expression. Howe57 investigated the effect of EPA v. DHA-
rich fish oils on inflammatory mediators during a 16-week
double-blind crossover trial. They suggest that EPA-rich fish
oil may be more effective than DHA-rich oil in suppressing
IL-1b production, but this reduction was not significantly
different from DHA. In an earlier trial, Meydani8 reported a
Table 3. Neutrophil functions at weeks 0 and 12 of intervention*
(Mean values with their standard errors)
Treatment group
FO FOX SO SOX
Mean SEM Mean SEM Mean SEM Mean SEM
Superoxide production‡ week 0 0·14 0·02 0·15 0·02 0·12 0·02 0·13 0·01
(OD570nm) week 12 0·11 0·02 0·10 0·02 0·14 0·03 0·13 0·02
change 20·03 0·02 20·05 0·02 0·02 0·02 0·01 0·02
n 11 10 11 8
Bactericidal activity§ week 0 96 1 96 1 96 1 93 1
(% killing) week 12 93 1 95 1 94 1 96 1
change 23 1 21 1 21 2 2 2
n 10k 10 10k 7k
Chemotaxis week 0 2·15 0·05 2·17 0·07 2·16 0·06 2·07 0·07
(mm/90min) week 12 2·03 0·08 2·23 0·07 1·98 0·09 2·11 0·10
change 20·13 0·11 0·06 0·11 20·18 0·11 0·04 0·12
n 11 10 11 8
Adherence† week 0 0·17 0·04 0·23 0·05 0·25 0·04 0·21 0·02
(OD570nm) week 12 0·31 0·05 0·32 0·04 0·26 0·04 0·27 0·03
change 0·15 0·06 0·09 0·05 0·01 0·06 0·06 0·02
n 10k 10 10k 8
FO, fish oil; FOX, fish oil and exercise; SO, sunflower oil; SOX, sunflower oil and exercise; TC, OD, optical density.
* Data were analysed with a 3-factor repeated measures ANOVA with interaction for oil, exercise and time, with P,0·05 considered significant. No 3-factor interactions were
detected.
† Significant main effect of time, P,0·05.
‡ Significant oil £ time interaction, P,0·05.
§ Significant exercise £ time interaction, P,0·05.
kSubjects excluded due to insufficient harvesting of cells or technical problem with assay.
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reduction in TNFa IL-1b and IL-6 following 12 weeks of
supplementation with 2·4 g/d of EPA-rich fish oil; however
they did not evaluate the effects of DHA.
Varying doses of fatty acids may also account for inconsis-
tencies between reports of anti-inflammatory effects of n-3
PUFA. Trebble58 found a U-shaped dose–response relation-
ship between EPA intake and cytokine production, wherein
maximum inhibition occurred with 1 g EPA-rich oil/d.
However, a dose–response curve for DHA is yet to be
established. In studies using subjects characterised by elevated
cytokine production59–61, decreases in IL-1b, TNFa, IL-2 and
IFNg production by stimulated MNL have been elicited by
comparable or lower doses of n-3 PUFA than used in the
present study. The supplementation in this trial may have
been of insufficient dose to produce changes in cytokine pro-
duction, as although exhibiting some risk factors for CVD,
participants in this trial were generally healthy and did not
present with raised serum cytokines at baseline. With high
doses of n-3 PUFA, several studies have shown a reduction
in both cytokine production and neutrophil function16,18,53,61.
Regular moderate exercise (2·5 h/week) has been shown to
decrease MNL production of TNFa and IFNg in subjects
with risk factors for CVD26 and to reduce the pro-inflamma-
tory cytokines, C-reactive protein, IL-1, IL-6 and IFNg in
patients with coronary artery disease25. Much research has
focused on the independent effect of exercise in populations
with elevated inflammatory markers, and data from random-
ised controlled trials are conflicting62. Variations in protocol
may partially explain the differences in cytokine production
as investigators have used a range of MNL stimulants includ-
ing lipopolysaccharide6,58 and phytohaemagglutinin26. Fur-
thermore, the small sample size and large inter-individual
subject variation may have limited our ability to detect effects
of intervention (fish oil or exercise) compared to controls.
While several studies have investigated the effect of an
acute exercise bout on neutrophil respiratory burst, chemotaxis
and adherence, these reports are inconsistent and likely to be
confounded by factors such as training status, exercise inten-
sity and population differences31,32. Fewer studies have
investigated the effect of regular exercise training on
Table 4. Cytokine production from stimulated neutrophils at baseline and following intervention with fish oil (FO) and exercise (FOX) or sunflower oil
(SO) and exercise (SOX)*




FO FOX SO SOX
Mean SEM Mean SEM Mean SEM Mean SEM
LT† Con A week 0 8·52 2·13 13·41 6·62 7·28 1·00 10·43 2·26
week 12 5·91 1·54 5·39 0·81 5·91 1·22 5·58 0·99
change 22·61 1·41 22·10 1·36 21·36 1·78 24·85 2·24
n 7 5‡ 7 6
LT† PHA week 0 30·26 4·30 30·04 6·53 36·71 6·96 32·37 7·27
week 12 24·24 5·65 15·95 2·94 23·46 4·54 17·93 4·83
change 26·02 4·61 214·10 6·15 27·76 2·84 214·44 8·01
n 7 6 63 6
IFNg Con A week 0 23·46 5·92 26·39 7·53 18·38 3·78 23·96 6·03
week 12 21·52 5·80 31·52 1·13 23·31 6·04 26·59 6·47
change 21·94 2·95 5·14 8·10 4·93 6·01 2·63 6·59
n 7 6 7 6
IFNg PHA week 0 17·50 5·32 24·66 10·25 15·64 6·38 14·09 3·57
week 12 16·56 3·03 18·26 5·44 14·77 5·88 15·83 6·19
change 20·94 3·60 26·41 7·73 20·88 7·18 1·74 4·55
n 7 6 7 6
IL-2† PHA week 0 0·80 0·40 0·71 0·28 1·88 0·78 0·63 0·33
week 12 0·45 0·25 0·24 0·08 0·51 0·16 0·18 0·05
change 20·35 0·36 20·45 0·23 21·29 0·80 20·58 0·35
n 7 5‡ 6‡ 5‡
IL-1b† LPS week 0 0·37 0·19 0·44 0·20 0·65 0·35 0·46 0·20
week 12 1·30 0·30 1·16 0·35 1·00 0·15 1·56 0·33
change 0·67 0·34 0·73 0·28 0·36 0·37 1·10 0·34
n 6‡ 6 7 6
IL-6† LPS week 0 3·00 0·85 5·80 2·34 4·97 2·28 4·55 2·12
week 12 8·22 1·60 7·25 0·65 7·54 1·81 11·33 1·63
change 5·22 2·22 1·45 1·83 2·57 2·74 6·78 2·44
n 7 6 7 6
TNFa† LPS week 0 0·42 0·16 0·32 0·08 0·56 0·16 0·60 0·23
week 12 2·08 0·37 1·53 0·52 1·82 0·39 2·15 0·60
change 1·67 0·45 1·21 0·50 1·26 0·35 1·54 0·61
n 7 6 7 6
LT, lymphotoxin; Con A, concanavalin A; PHA, phytohaemagglutinin; IFNg, interferon g; LPS, lipopolysaccharide.
* Data were analysed with a 3-factor repeated measures ANOVA with interaction for oil, exercise and time, with P,0·05 considered significant. No 3-or 2-factor interactions
were detected.
† Significant main effect of time, P,0·05.
‡ Subject excluded due to insufficient specimen.
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neutrophil function, although there is some evidence to
suggest that it may reduce neutrophil respiratory burst
activity31. While we observed no effect of regular aerobic
training on superoxide production, we did observe a protective
effect of exercise on bactericidal activity. As for other
measures of neutrophil function, there is limited data on the
effect of aerobic exercise training on this parameter. Lewicki63
reported that bactericidal activity of trained sportsmen was
significantly reduced compared to untrained individuals. Con-
versely, Benoni64 observed an increase in bactericidal activity
during the sports season of elite basketball players, which
returned to baseline levels at the end of the season. Although
significant, the change in bactericidal activity observed in this
trial was marginal and unlikely to be of clinical significance.
In this study, supplementation with DHA-rich tuna fish oil
resulted in a significant reduction in superoxide production
by stimulated neutrophils. This finding gives support to
previous studies which have found decreases in superoxide
production of 14–64% following 4–6 weeks of supplemen-
tation with EPA-rich oil providing .4 g n-3 PUFA/d16,19,65,
which was substantially more than that provided in the pre-
sent study. Although differences in the methods by which
the reactive oxygen species are measured may explain
some of the variation in the magnitude of change in
superoxide production, it is more likely to be a function
of the neutrophil stimulus used. Fisher65 and Varming19
used particles acting on neutrophil surfaces while we and
others who found a smaller effect used the soluble stimulus
PMA which acts on intracellular protein kinase C (PKC)16.
Conversely, lower doses of n-3 PUFA (0·27–2·25 g/d) have
not been shown to influence superoxide production by
neutrophils21.
The importance of modifying superoxide production is
linked to its role in CVD, particularly in the pathogenesis of
atherosclerosis. Reactive oxygen species, including superox-
ide, induce endothelial expression of cell adhesion
molecules66, increase microvessel permeability67 and oxidised
LDL68. Within the endothelium, excess reactive oxygen
species can lead to a decrease in nitric oxide bioavailability69,
and this can impact negatively on vascular function. Moreover
reactive oxygen species play a role in the activation of nuclear
factor-kb, a transcription factor that regulates the production
and expression of numerous inflammatory cytokines and cell
adhesion molecules70. The mechanism by which n-3 PUFA,
particularly DHA, decreases superoxide production may be
related to its incorporation into neutrophil membrane lipids.
While we did not measure the fatty acid composition of
neutrophil membranes, it is reasonable to assume that DHA
incorporation into these cells would have mirrored the
increase seen in erythrocyte membranes. Evidence for this
relationship may be seen in the negative correlation between
superoxide production and the increased incorporation of
DHA in erythrocyte membranes.
While DHA as a NEFA has been shown to directly and
strongly activate the neutrophil respiratory burst71, increasing
the n-3 PUFA concentration of neutrophil membrane phospho-
lipids, such as phosphatidylcholine and phosphatidylinositol,
may alter the ability to activate signaling molecules such as
PKC, which are involved in oxidase stimulation. DHA, by
replacing AA in the sn-2 position of the phospholipid, leads
to the generation of DHA-containing diacylglycerol, possibly
compromising PKC translocation and/or activation. The
stimulus used in our studies, PMA, directly interacts with
PKC to activate the NADPH oxidase. However as we and
others have previously shown, PUFA act via phosphatidic
acid which is involved in the generation of diacylglycerol, a
process stimulated by PMA72–74. It is therefore not surprising
that DHA supplementation suppresses T cell PKCu lipid raft
recruitment75. Indeed Madani76 reported that DHA-containing
diacylglycerol and AA-containing diacylglycerol activated
different PKC isozymes differently in vitro. Finally intracellu-
lar AA is considered to promote the activation of small guano-
sine 50-triphosphate binding protein Rac, a component of the
neutrophil oxidase77. Replacing AA with DHA in the phos-
pholipids may hinder this part of the oxidase activation
process.
Our findings demonstrate that under these conditions, n-3
supplementation had no effect on ex vivo cytokine production
by MNL and emphasises the controversies in this field. While
we would have expected that this type of treatment should
have resulted in reduced cytokine production5–8,58,61,78,79,
several studies have demonstrated either no
effect22,23,52,59,80–85 or even increased production of cyto-
kines86. These discrepancies are difficult to explain and
cannot be simply due to the dose of n-3. Other factors are
likely to be the type of n-3 PUFA used, and the individual’s
health status, sex and age. Whether or not technical factors
contribute to this difference needs to be given consideration.
Our studies were conducted under NATA accredited con-
ditions, ensuring a high level of standardisation and reprodu-
cibility in conducting cellular tests at different time
intervals. Interestingly, contributing to these variations is the
finding that polymorphism in the TNF gene and promoter
can influence the effects of fish-oil supplement on the pro-
duction of this cytokine87. Similarly, studies addressing n-3
supplementation and neutrophil functions have produced con-
flicting results, reporting either a decrease3,15–17,19, no
effect13,21–23,52,84 or increase86 in neutrophil function.
Again, while more careful consideration of experimental con-
ditions needs to be given, it is evident that doses, n-3 fatty acid
type and the neutrophil stimulus used may give rise to these
differences.
In summary, the present study found that supplementation
with DHA-rich fish oil reduces superoxide production from
stimulated neutrophils, while regular moderate exercise
training protects bactericidal activity. Neither of these
functions was enhanced by the combination of interventions.
However it is unclear whether these changes are of biologi-
cal significance. Other neutrophil functions (chemotaxis,
adherence and cytokine production) were unaffected by
intervention. Supplementation with about 2g n-3 PUFA/d
therefore did not inhibit immune function in this study.
Differences between this and other studies investigating
the effect of n-3 PUFA on markers of inflammation may
be due to variations in either the dose or fatty acid compo-
sition (i.e. DHA/EPA) of fish oil, clearly emphasising the
need for a well-controlled dose–response study which
differentiates between the effects of EPA from those of
DHA. Nevertheless, given the independent beneficial effects
of moderate exercise and fish-oil supplementation on CVD
risk parameters, we support recommendations to combine
these lifestyle interventions.
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